Intellia Therapeutics Inc buy Wells Fargo & Company
Start price
18.11.24
/
50%
€13.35
Target price
18.11.25
€66.07
Performance (%)
-46.02%
End price
19.11.25
€7.20
Summary
This prediction ended on 19.11.25 with a price of €7.20. Massive losses of -46.02% were the result for the BUY prediction by Wells_Fargo___Compan. Wells_Fargo___Compan has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 8.566% | 8.566% | 11.686% |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Wells Fargo & Company from $80.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten
Current prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.50
28.02.25
28.02.25
€48.09
28.02.26
28.02.26
22.74%
27.02.26
27.02.26
Stopped prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.49
08.08.25
08.08.25
-
08.08.26
08.08.26
22.89%
27.02.26
27.02.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.22
10.01.25
10.01.25
€58.40
10.01.26
10.01.26
-11.94%
11.01.26
11.01.26